eteraflex connects

Main Menu
Contact Us
Flyout Menu

Advancing clinical development in 
India with confidence

 eteraflex connects combines U.S. clinical governance with India’s proven research ecosystem to help oncology-focused biotechnology, pharmaceutical, and medical-device companies execute compliant, audit-ready clinical programs — led by strategy, executed under a DCGI-registered CRO.

Talk to Our Experts

WHO WE ARE 

Your strategic clinical development partner

We partner with global life-sciences companies to lead clinical development in India — setting regulatory, CMC, and operational strategy, then executing it. From regulatory strategy through commercialization, we help sponsors reduce complexity, manage risk, and move oncology programs forward.

OUR STORY

Nearly two decades of clinical research experience

For nearly two decades, our team has supported global sponsors with predictable regulatory execution, trusted investigator networks, and disciplined clinical operations — built on long-standing regulatory relationships and an unwavering commitment to quality.

Why Global Sponsors Choose eteraflex

U.S. Clinical Governance 

strategic oversight aligned with global regulatory expectations; in-house FDA and DCGI expertise, designed to EMA/PMDA/MFDS/NMPA. 

Regulatory Confidence

deep CDSCO and Subject Expert Committee (SEC) experience. 

India Execution Excellence

premier oncology sites with nationwide operational reach. 

Quality Without Compromise

consistent, audit-ready execution across every engagement. 

 Global expertise driving clinical research excellence 

Our leadership and advisory team combine decades of expertise in clinical development, regulatory strategy, pharmaceuticals, medical devices, and public health — guiding global sponsors from development through commercialization. 

Stephane_Marzabal_7404

Stephane Marzabal, PhD

Program Leadership, Governance & Execution Strategy

Stephane Marzabal, PhD, brings over 25 years of leadership experience across the pharmaceutical and biotechnology industry, with deep expertise in global program leadership, clinical operations, and organizational transformation.

 
Learn more
Roland_Winger headshot

Roland Winger

Clinical Operations & Medical Device Development

 

Roland Winger is a senior clinical operations executive with nearly two decades of experience leading global clinical programs across biotechnology and medical device development.

 
Learn more
Dr.BalramBhargava_1

Dr. Balram Bhargava

Strategic Advisor – Public Health & Regulatory Leadership

 

Balram Bhargava is a distinguished physician-scientist and former Director-General of the Indian Council of Medical Research (ICMR), India’s apex biomedical research institution.

 
 
Learn more

NETWORK & TECHNOLOGY

Technology-enabled clinical research ecosystem

Our integrated network of premier research sites, investigators, laboratories, and digital platforms supports faster patient recruitment, predictable execution, and real-time operational visibility across every phase. 

Nationwide Research Network 

  • Premier oncology research sites 
  • Experienced investigators 
  • Central laboratory partners 
  • Imaging & diagnostic partners 
  • Established CDSCO relationships 
  • Integrated clinical technology platform 

Digital Clinical Intelligence 

  • ClinTrialX — end-to-end clinical trial management 
  • HeliX — centralized operational oversight 
  • Real-time analytics — live study performance insights 
  • Risk monitoring — proactive quality and compliance management 
  • Compliance tracking — continuous regulatory visibility 
  • SECTION 5 — WHY SPONSORS CHOOSE e

Why Sponsors Choose eteraflex

Regulatory Intelligence Built for Speed and Compliance

Integrated 
strategy + execution 

In-house FDA + DCGI regulatory 

Oncology depth & enrollment 

Proven 
quality 

Local execution + global governance 

Ready to advance your clinical development in India? 

Partner with eteraflex connects to navigate India’s regulatory landscape, strengthen execution, and achieve clinical milestones with confidence.

Schedule a Consultation
Scroll to Top

Stephane Marzabal, PhD

Program Leadership, Governance & Execution Strategy

Stephane Marzabal, PhD, brings over 25 years of leadership experience across the pharmaceutical and biotechnology industry, with deep expertise in global program leadership, clinical operations, and organizational transformation. Over his career, he has guided complex assets across development phases, including multiple IND submissions and worldwide product launches within highly matrixed, multi-partner environments.

Dr. Marzabal is recognized for designing governance models that keep programs aligned, decisions timely, and execution disciplined—particularly in settings where small and emerging biotechs face resource constraints and heightened execution risk. In 2016, he co-founded SYNOV Solutions, where he advises life sciences organizations on leadership effectiveness, operating models, and portfolio execution during critical growth phases.

At eteraflex connects, Dr. Marzabal supports sponsors and internal teams by reinforcing program governance, execution rigor, and decision readiness, helping prevent late-stage drift and ensuring development programs progress with clarity and control.

 

Roland Winger

Clinical Operations & Medical Device Development

 

Roland Winger is a senior clinical operations executive with nearly two decades of experience leading global clinical programs across biotechnology and medical device development. His background spans early- and late-stage trials, organizational scale-up, and regulatory success across the U.S. and Europe.

Most recently, Mr. Winger served as Senior Vice President of Clinical Operations at Allakos, Inc., where he led multiple Phase I–III programs for a novel monoclonal antibody platform and helped scale clinical operations in preparation for public markets. Previously, as Vice President of Clinical Operations at ZS Pharma, he oversaw global trials supporting Lokelma®, which achieved FDA and EMA approval and was later acquired by AstraZeneca. Earlier in his career, he served as Chief Operating Officer at Ash Access Technology, leading the clinical development of medical devices in nephrology and vascular access.

At eteraflex connects, Mr. Winger advises on clinical operations strategy, execution excellence, and operational risk mitigation, with a focus on maintaining sponsor control across complex, multi-vendor trial environments.

Dr. Balram Bhargava

Strategic Advisor – Public Health & Regulatory Leadership

Balram Bhargava is a distinguished physician-scientist and former Director-General of the Indian Council of Medical Research (ICMR), India’s apex biomedical research institution. With over three decades of experience spanning clinical medicine, academic research, and national health leadership, he has played a central role in strengthening India’s clinical research and translational science ecosystem.

A cardiologist by training and former Professor at AIIMS, New Delhi, Dr. Bhargava has contributed significantly to medical innovation and policy development, supporting initiatives that advanced regulatory-scientific coordination and expanded research infrastructure across India. He has authored over 300 peer-reviewed publications and has been recognized nationally and internationally for his contributions to healthcare and biomedical research.

At eteraflex connects, Dr. Bhargava provides strategic guidance on regulatory engagement, public health policy alignment, and institutional collaboration frameworks. His experience navigating complex research environments supports our mission to deliver governance-driven, execution-focused clinical and regulatory solutions for global sponsors operating in India.